DRUG PRICING FOR PERSONALISED MEDICINE

REGULATORY ASPECTS OF GENOTOXIC IMPURITIES

Is Blockchain the Right Technology for the Pharma Supply Chain?

NOVO NORDISK PHAMATECH - ENSURING QUALITY ASSURANCE

Compelling Pre-clinical Models

HEALTHCARE EVOLUTION

FOUND IN TRANSLATION

COMPUTER AIDED DRUG DESIGN IN PHARMA R&D

MESSY MARKETING

A QUALITY BY DESIGN APPROACH

Get instant access to latest e-book

LATEST NEWSRead more...

04

Oct 2019

Prometheus Biosciences, Inc., Enters Into Multi-Target Strategic Collaboration with Takeda to Develop Targeted Therapies for Inflammatory Bowel Disease

Prometheus Biosciences Inc a biopharmaceutical company committed to the discovery development and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases announced that it has en...

04

Oct 2019

Goldfinch Bio Announces Licensing Agreement with Takeda for CB1 Monoclonal Antibody for the Treatment of Rare and Metabolic Kidney Diseases

Goldfinch Bio a USbased clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases today announced it entered into a license agreement with Takeda Pharmaceutical Company Limited Takeda for worldwide rights to a preclinical peri...

03

Oct 2019

Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening

Xylyx Bio a pioneer in tissuespecific extracellular matrix biomaterials today announced the development of substrates for antifibrotic drug discovery as the next stage of its pipeline of preclinical cell culture products

03

Oct 2019

Cellular Biomedicine Group Announces New Facility to Expand Research and Development and to Support Clinical Development

Cellular Biomedicine Group Inc a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases today announced it has entered into a lease agreement to build an approximately square foot facility in Rockville Maryland to augme...

press releasesRead more...

04

Oct 2019

Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base

Rentschler Biopharma SE a worldclass contract development and manufacturing organization CDMO for biopharmaceuticals today reported that it will further enhance and develop the existing collaboration in Japan with Summit Pharmaceuticals International Corporation SPI a wholly owned subsidiary of Sumi...

04

Oct 2019

MedicaSafe Announces Partnership with Amneal Pharmaceuticals

MedicaSafe Inc today announced a partnership with Amneal Pharmaceuticals Incto provide Amneals generic version of Suboxone buprenorphine and naloxone as part of MedicaSafes datagenerating medication system This partnership provides a system aimed to deliver realtime information about the patients me...

04

Oct 2019

Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Niraparib for the Treatment of Metastatic Castration-Resistant Prostate Cancer

The Janssen Pharmaceutical Companies of Johnson Johnson announced today that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation for niraparib an orallyadministered poly ADPribose polymerase PARP inhibitor for the treatment of patients with BRCA genemutated metastat...

03

Oct 2019

SIRIO Group introduces one-stop-platform for plant-based nutraceuticals at SupplySide West

Ahead of SupplySide West Sirio Pharma Booth the nutraceutical contract development innovation and manufacturing organization CDIMO unveils full spectrum of onestopservices for all plantbased products and announces plans for The company is using the event to actively promote its integrated solut...

EventsRead more...

08 - 09

Oct 2019

4th Annual Biomarkers & Precision Medicine USA Congress

Oxford Global Marketing Ltd
DoubleTree by Hilton Hotel San Diego – Mission Valley

08 - 08

Oct 2019

European Epidemiological Forum 2019

H10 Cubik

08 - 08

Oct 2019

European Epidemiological Forum 2019

Life Science Academy
Barcelona

08 - 11

Oct 2019

World ADC San Diego 2019

Manchester Grand Hyatt San Diego

09 - 10

Oct 2019

Wearable Injectors and Connected Devices

Copthorne Tara Hotel

09 - 10

Oct 2019

Hypertension and Cardiovascular Diseases

Pulsus
Madrid

AirBridgeCargo - Air frieght solutions for your Pharma

KNOWLEDGE BANK

Interviews

Merck

Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

Articles

Metal Organic Framework-Mesoporous Silica Nanoparticle Composite for Controlled Drug Delivery

Most of the chemotherapeutic drugs suffer from uncontrolled and nonspecificdelivery that lead to lethal effects to the body thus limits their usesSosevere side effects of chemotherapeutic drugs

Research Insights

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to in

Case Studies

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime

Techno Trends

UNC Lineberger Researchers Discover Experimental Compound to Block Lymphoma

The University of North Carolina UNC Lineberger Comprehensive Cancer Center researchers have discovered a hyperactive cell that contributes to tumor growth in primary effusion lymphoma and a potential treatment strategy to block down its downstream effects

White Papers

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward

Advisory Board

Stella

Sanjoy Ray

Rustom

Phil

Neil J

Laurence

Kenneth I

Georg C

Frank A

Douglas

Christopher-

Alan S Louie

EDITORIAL SECTION

STRATEGY

REDUCTION OF HEALTH COSTS

Since autumn the first package of costcutting measures in Switzerlands healthcare system is being reviewed One of the measures is the socalled refere...

RESEARCH DEVELOPMENT

Academic Ventures and Professional Service Companies

Over the past few decades life science and pharma have been characterised by a series of radical changes that have been at the origin of an impressive...

CLINICAL TRIALS

The Virtual World of Digital Clinical Trials

Emerging technologies have the potential to fundamentally alter how patients engage with and participate in clinical trials Creating a digital strateg...

MANUFACTURING

ADVANCES IN SPRAY DRYING FOR THE IMPROVED DELIVERY OF POORLY SOLUBLE DRUGS

Spray drying is an important unit operation first patented in Essentially the technique involves the pumping of a solution through a nozzle into a dr...

Information Technology

IOT AND AI CREATE ‘SMART’ DIGITAL ASSISTANTS

was the year where pharma realised that Big Data could dramatically increase the value of data produced during drug development or coming from Electr...

EXPERT Talk

The Pharmaceutical Supply Chain from a CDMO’s Perspective

The primary change we see is that of market dynamics and rapid growth resulting in an increased complexity in the supply chain In an era of globalisat...

DRUG PRICING FOR PERSONALISED MEDICINE

REGULATORY ASPECTS OF GENOTOXIC IMPURITIES

Is Blockchain the Right Technology for the Pharma Supply Chain?

NOVO NORDISK PHAMATECH - ENSURING QUALITY ASSURANCE

Compelling Pre-clinical Models

HEALTHCARE EVOLUTION

FOUND IN TRANSLATION

COMPUTER AIDED DRUG DESIGN IN PHARMA R&D

MESSY MARKETING

A QUALITY BY DESIGN APPROACH

Get instant access to latest e-book

LATEST NEWSRead more...

04

Prometheus Biosciences, Inc., Enters Into Multi-Target Strategic Collaboration with Takeda to Develop Targeted Therapies for Inflammatory Bowel Disease

04

Goldfinch Bio Announces Licensing Agreement with Takeda for CB1 Monoclonal Antibody for the Treatment of Rare and Metabolic Kidney Diseases

03

Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening

03

Cellular Biomedicine Group Announces New Facility to Expand Research and Development and to Support Clinical Development

press releasesRead more...

04

Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base

04

MedicaSafe Announces Partnership with Amneal Pharmaceuticals

04

Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Niraparib for the Treatment of Metastatic Castration-Resistant Prostate Cancer

03

SIRIO Group introduces one-stop-platform for plant-based nutraceuticals at SupplySide West

EventsRead more...

08 - 09

4th Annual Biomarkers & Precision Medicine USA Congress

08 - 08

European Epidemiological Forum 2019

08 - 08

European Epidemiological Forum 2019

08 - 11

World ADC San Diego 2019

09 - 10

Wearable Injectors and Connected Devices

09 - 10

Hypertension and Cardiovascular Diseases

Advertisements

TOP ARTICLES

1

Facing the Autoimmune Epidemic Prevention and treatment by novel vaccines

2

Bio-Inspired Nanomedicine An Emerging Trend For Drug Targeting Into Cancer Cells

3

Sunlight Assisted Degradation of Waste Chemicals Green Technology for Pharmaceutical Waste Management

4

Ligand Decorated Theranostic Nanomedicines

5

Industry 4.0: A Closed Micronisation System

KNOWLEDGE BANK

Merck

Metal Organic Framework-Mesoporous Silica Nanoparticle Composite for Controlled Drug Delivery

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study

UNC Lineberger Researchers Discover Experimental Compound to Block Lymphoma

Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper

Advisory Board

EDITORIAL SECTION

REDUCTION OF HEALTH COSTS

Academic Ventures and Professional Service Companies

The Virtual World of Digital Clinical Trials

ADVANCES IN SPRAY DRYING FOR THE IMPROVED DELIVERY OF POORLY SOLUBLE DRUGS

IOT AND AI CREATE ‘SMART’ DIGITAL ASSISTANTS

The Pharmaceutical Supply Chain from a CDMO’s Perspective